Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|CYP2D6 Polymorphism
Interventions: DRUG: Tamoxifen
Sponsor: Western Sydney Local Health District
Collaborators: St George Hospital, Australia